← EU Feed

SIBIONICS: From Data to Clinical Action: New Directions in Diabetes Management at ATTD 2026

SIBIONICS: From Data to Clinical Action: New Directions in Diabetes Management at ATTD 2026

AI Briefing

  • Clinical CGM use moves beyond data visualization to empower patient education and behavior change.
  • New technologies and tools facilitate more accurate and personalized glucose monitoring.
  • Integration of CGM data with AI and machine learning for predictive analytics and enhanced patient outcomes.
Advertisement
Read Original Article